Jill Suzanne Chlebus, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 509 S Lewis St, Blue Mound, IL 62513 Phone: 217-692-2535 |
News Archive
Hemodynamic Therapeutics, Inc. (HTI), a portfolio company of Cato BioVentures, announces the successful completion of its initial Phase 2 clinical study of its lead compound ("HTI-101"), a patented low-dose small-molecule investigational therapy intended for patients with treatment-resistant hypertension.
Elsevier, a world-leading publisher of medical information products and services, announced today that in cooperation with Peking University Medical Press (PUMP) it has donated over 5,000 books to medical universities, colleges and schools in Midwest China.
As new genes are linked to breast cancer occurring in families and as genetic testing becomes more important in directing treatment for newly diagnosed patients, a substantial number of those at the highest risk are not getting tested.
Childhood obesity is a serious public health concern that can have a profound impact on children's health and well-being.
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
› Verified 3 days ago